Location History:
- Rockville, MD (US) (2019)
- Gaithersburg, MD (US) (2016 - 2022)
Company Filing History:
9 out of 3,539 
4 out of 547 
3 out of 2,119 
Years Active: 2016-2022
Title: The Innovative Contributions of Samarjit Patnaik
Introduction
Samarjit Patnaik is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of central nervous system (CNS) conditions. With a total of 9 patents to his name, Patnaik's work has the potential to impact the lives of many individuals suffering from various health issues.
Latest Patents
One of Patnaik's latest patents is focused on autophagy inducers for the treatment of CNS conditions. This invention provides a compound of formula (I), which includes ginsenoside Rg2 of structure (II) or a combination thereof. This compound is designed for use in treating or preventing conditions that respond to the induction of autophagy in the brain of a mammal in need. Another significant patent involves substituted pyrazolopyrimidines as glucocerebrosidase activators. This patent describes substituted pyrazolopyrimidines and dihydropyrazolopyrimidines, their methods of manufacture, and their use in treating lysosomal storage disorders such as Gaucher disease.
Career Highlights
Throughout his career, Patnaik has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Kansas Medical Center Research Institute. His work in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Patnaik has collaborated with notable colleagues, including Juan Jose Marugan and Noel Terrence Southall. These partnerships have further enhanced his research efforts and have led to innovative solutions in the medical industry.
Conclusion
Samarjit Patnaik's contributions to medical research through his patents and collaborations highlight his dedication to improving health outcomes. His innovative work continues to pave the way for advancements in the treatment of CNS conditions and lysosomal storage disorders.